GBMC investigators offer some of the most cutting edge treatment options available to those who are eligible and interested in participating. Through clinical trials, participants have the opportunity to explore treatment options not yet approved by the FDA and contribute to medical advancements that may benefit generations to come.
The FDA reviews and approves all investigational drug studies prior to initiating a given study at any U.S. location. Physicians offering clinical trials follow strict FDA guidelines to ensure patient safety is protected. All trials are approved for use by an Institutional Review Board (IRB) whose main function is to protect patients from unreasonable harm and side effects. The GBMC IRB reviews all open clinical trials on a continuous basis. Patients participating on clinical trials are monitored closely and reportable serious side effects are communicated to the study sponsor and IRB expeditiously.